Progyny, Inc. PGNY
We take great care to ensure that the data presented and summarized in this overview for Progyny, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PGNY
View all-
Black Rock Inc. New York, NY11.8MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.69MShares$199 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX6.88MShares$157 Million3.27% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.68MShares$84 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.27MShares$74.6 Million0.03% of portfolio
-
State Street Corp Boston, MA3.14MShares$71.7 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.44MShares$55.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.43MShares$55.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$41.7 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.65MShares$37.6 Million0.14% of portfolio
Latest Institutional Activity in PGNY
Top Purchases
Top Sells
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Insider Transactions at PGNY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 01
2025
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,977
-1.42%
|
$175,494
$22.34 P/Share
|
|
Apr 01
2025
|
David J Schlanger Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-0.84%
|
$41,646
$22.34 P/Share
|
|
Mar 04
2025
|
Allison Swartz EVP, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,417
-1.66%
|
$31,174
$22.0 P/Share
|
|
Mar 04
2025
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,350
-1.78%
|
$29,700
$22.0 P/Share
|
|
Mar 04
2025
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
25,989
-7.66%
|
$571,758
$22.0 P/Share
|
|
Mar 03
2025
|
Allison Swartz EVP, GC |
BUY
Grant, award, or other acquisition
|
Direct |
22,727
+21.06%
|
-
|
|
Mar 03
2025
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
127,272
+18.42%
|
-
|
|
Mar 03
2025
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,069
-2.66%
|
$45,518
$22.53 P/Share
|
|
Mar 03
2025
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,363
+31.86%
|
-
|
|
Mar 03
2025
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.11%
|
$7,986
$22.53 P/Share
|
|
Feb 28
2025
|
Allison Swartz EVP, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,551
-2.42%
|
$34,122
$22.88 P/Share
|
|
Feb 26
2025
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
5,873
-1.7%
|
$129,206
$22.98 P/Share
|
|
Feb 26
2025
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.44%
|
$3,982
$22.98 P/Share
|
|
Jan 02
2025
|
David J Schlanger Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,171
-0.95%
|
$36,907
$17.25 P/Share
|
|
Jan 02
2025
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,162
-1.4%
|
$104,754
$17.25 P/Share
|
|
Dec 26
2024
|
David J Schlanger Executive Chairman |
BUY
Open market or private purchase
|
Direct |
150,000
+39.65%
|
$2,100,000
$14.68 P/Share
|
|
Dec 23
2024
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
209,500
+32.18%
|
$2,933,000
$14.48 P/Share
|
|
Dec 02
2024
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-0.13%
|
$6,720
$15.57 P/Share
|
|
Dec 02
2024
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,617
-5.92%
|
$39,255
$15.57 P/Share
|
|
Nov 29
2024
|
Allison Swartz EVP, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-2.07%
|
$20,280
$15.48 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 233K shares |
|---|---|
| Open market or private purchase | 360K shares |
| Open market or private sale | 10.7K shares |
|---|---|
| Payment of exercise price or tax liability | 116K shares |